Zimmer Biomet Holdings Price Target Raised by RBC

Zimmer Biomet Holdings Price Target Raised by RBC

Zimmer Biomet Holdings received a price-target increase Wednesday from RBC Capital Markets, a week after the maker of orthopedic reconstructive products said it received from the Food & Drug Administration a successful clearance of a warning letter related to its Zhejiang, China manufacturing facility. The new price target from RBC is $140 per share, up from $133. The stock closed Tuesday at $127.22, up 1.8% from where it closed before […]

Read More ˃
Baxter Enters into Drug Development Collaboration

Baxter Enters into Drug Development Collaboration

Baxter International, a provider of renal and hospital products, said early Wednesday that it has entered into an agreement with India-based Dorizoe Lifesciences Limited that will facilitate the accelerated development of more than 20 generic injectable products. Under the deal, Dorizoe will work with Baxter to perform certain product development activities, while Baxter will hold worldwide manufacturing and commercialization rights for the products. The deal covers anti-infectives, oncolytics, and cardiovascular […]

Read More ˃
Trillium Therapeutics Expands Trial of Cancer Drug

Trillium Therapeutics Expands Trial of Cancer Drug

Trillium Therapeutics said Wednesday it has further expanded its current intravenous dosing trial of TTI-621 following promising early evidence of anti-tumor activity in patients with both myeloid and lymphoid malignancies. Changes to the trial of TTI-621, the company’s lead program, include an additional cohort of patients with Hodgkin lymphoma treated with a combination of TTI-621 and the PD-1 checkpoint inhibitor nivolumab; two additional cohorts of patients with T- and B-cell […]

Read More ˃
Tech Data Posts Fiscal Q1 Beat

Tech Data Posts Fiscal Q1 Beat

Tech Data reported Thursday financial results for fiscal Q1, with better-than-expected earnings and revenue; it also provided in line guidance for Q2 earnings. For the quarter ended April 30, the wholesale distributor of technology products posted non-GAAP earnings of $1.87 per share, compared with the prior-year period’s $1.05 per share. Analysts polled by Capital IQ were expecting EPS of $1.33. Revenue was $7.66 billion, up 29% from $5.96 billion in […]

Read More ˃
Triumph Group Gains

Triumph Group Gains

Triumph Group said Monday it signed a new memorandum of agreement with Boeing (BA) that supports the company’s participation in Boeing’s growth platforms within their commercial aircraft, defense programs, and global services market. Shares of Triump climbed more than 4% intraday. This expands Triumph’s traditional roles in aerospace structures and precision components into the areas of integrated systems and services, it said in a statement. Under the agreement, the companies […]

Read More ˃